Prognostic Biomarkers in Patients With Endometrial Cancer

Inclusion Criteria

• •Women who were eligible and evaluable for the GOG-0210 molecular staging protocol in women with endometrial cancer
• •* Women who were registered during the unrestricted enrollment period (through 9/23/07) will automatically qualify
• •* Women who were registered during the restricted enrollment period (after 9/23/07) will only be considered if needed
• •Women who had histologically confirmed endometrioid endometrial adenocarcinoma regardless of stage or grade
• •Women who have defective DNA mismatch repair and are microsatellite instability positive (MSI+ and MSI-low)
• •Women who consented to allow their specimens and clinical data to be used for future cancer research
• •Women who have sufficient high-quality genomic DNA from tumor available for mutation analysis of ATR